Abstract

SPLUNC1 is a multifunctional protein of the airway with antimicrobial properties. We previously reported that it displayed antibiofilm activities against P. aeruginosa. The goal of this study was to determine whether (1) the antibiofilm property is broad (including S. aureus, another prevalent organism in cystic fibrosis); (2) the α4 region is responsible for such activity; and (3), if so, this motif could be structurally optimized as an antimicrobial peptide with enhanced activities. We used S. aureus biofilm-prevention assays to determine bacterial biomass in the presence of SPLUNC1 and SPLUNC1Δα4 recombinant proteins, or SPLUNC1-derived peptides (α4 and α4M1), using the well-established crystal-violet biofilm detection assay. The SPLUNC1Δα4 showed markedly reduced biofilm prevention compared to the parent protein. Surprisingly, the 30-residue long α4 motif alone demonstrated minimal biofilm prevention activities. However, structural optimization of the α4 motif resulted in a modified peptide (α4M1) with significantly enhanced antibiofilm properties against methicillin–sensitive (MSSA) and–resistant (MRSA) S. aureus, including six different clinical strains of MRSA and the well-known USA300. Hemolytic activity was undetectable at up to 100μM for the peptides. The data warrant further investigation of α4-derived AMPs to explore the potential application of antimicrobial peptides to combat bacterial biofilm-related infections.

Highlights

  • IntroductionHuman SPLUNC1 (short palate lung and nasal epithelial clone 1) is a 256-amino acid multifunctional protein of the innate immunity secreted in the human respiratory tract

  • Human SPLUNC1 is a 256-amino acid multifunctional protein of the innate immunity secreted in the human respiratory tract

  • Bacteria (MSSA and MRSA), treated with the mutant protein (Wingtip, 5μg/mL), displayed 43% and 65.5% of biofilm formation, respectively compared to 13.8% and 43% biofilm mass by the same bacterial strains treated with SPLUNC1-we first compared SPLUNC1 (WT)

Read more

Summary

Introduction

Human SPLUNC1 (short palate lung and nasal epithelial clone 1) is a 256-amino acid multifunctional protein of the innate immunity secreted in the human respiratory tract. It binds to lipopolysaccharide (LPS) and exerts bacteriostatic as well as antibiofilm effects[1,2,3,4]. It acts as a fluid-spreading surfactant, which facilitates mucus clearance[5,6,7].

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call